𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessment of adaptive functioning in huntington's disease

✍ Scribed by Dr. Frederick W. Bylsma; Johannes Rothlind; Michelle R. Hall; Susan E. Folstein; Jason Brandt


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
682 KB
Volume
8
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The Huntington's Disease Activities of Daily Living (HD–ADL) scale is a 17‐item informant‐completed instrument for rating adaptive functioning in Huntington's disease (HD) patients. To assess the reliability and clinical correlates of the HD–ADL, it was administered along with the Mini‐Mental State Exam (MMSE) and Quantified Neurological Exam (QNE) to 93 HD patients. The HD‐ADL has high internal consistency (coefficient alpha = 0.91). Principal components factor analysis of the HD‐ADL revealed four factors (General Functioning, Domestic Activities, Home Upkeep, and Family Relationships) accounting for 72% of the total variance. MMSE score, motor impairment score, and duration of disease were the best predictors of HD‐ADL score. Similar results were obtained in an independent replication sample of patients. The HD‐ADL scores correlate with Shoulson and Fahn's total functional capacity (TFC) index (r = −0.89). The HD‐ADL scale is a reliable and valid instrument for assessing adaptive function in HD patients.


📜 SIMILAR VOLUMES


Functional decline in Huntington's disea
✍ Dr. Andrew Feigin; Karl Kieburtz; Kathy Bordwell; Peter Como; Kimberly Steinberg 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

## Abstract We prospectively evaluated 129 patients with manifest Huntington's disease (HD) to determine the rate of illness progression and the clinical features that correlate with functional decline. A single examiner evaluated each patient using the HD Functional Capacity Scale. Standardized mo

Assessment of coenzyme q10 tolerability
✍ Dr. A. Feigin; K. Kieburtz; P. Como; C. Hickey; D. Abwender; C. Zimmerman; K. St 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

## Abstract We performed a 6‐month open‐label trial to evaluate the tolerability and efficacy of coenzyme Q10 (CoQ) in 10 patients with Huntington's disease (HD), Subjects were evaluated at baseline, 3 months, and 6 months using the HD Rating Scale (HDRS), the HD Functional Capacity Scale (HDFCS),

Assessment of simple movements reflects
✍ Carsten Saft; Jürgen Andrich; Nina-Marie Meisel; Horst Przuntek; Thomas Müller 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Clinical rating, caudate atrophy, disturbed movement performance, neuropsychological testing, and age-related genetic disease load (CAG index) are tools that reflect impairment after onset of Huntington's disease (HD). Objectives were to compare scored HD symptoms, results of neuropsychological test

Clinical correlates of mitochondrial fun
✍ Christopher Turner; J. Mark Cooper; Anthony H. V. Schapira 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract Huntington's disease (HD) is caused by an abnormally expanded CAG repeat in the __IT__‐__15__ gene, which encodes a widely expressed protein called huntingtin. Abnormalities of mitochondrial respiratory chain function, specifically complex II/III, have been identified in HD striatum and

Huntington's disease: Objective assessme
✍ Ralf Reilmann; Silke Rumpf; Heike Beckmann; Raphael Koch; Erich B. Ringelstein; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

## Abstract ## Background: Postural deficits in Huntington's disease are linked to functional impairment. We investigated whether assessment of center‐of‐mass variability using posturography provides objective and quantitative measures that correlate to the severity of motor phenotype, functional